AstraZeneca PLC Files 6-K on AGM Results
Ticker: AZN · Form: 6-K · Filed: Apr 11, 2025 · CIK: 901832
| Field | Detail |
|---|---|
| Company | Astrazeneca PLC (AZN) |
| Form Type | 6-K |
| Filed Date | Apr 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: agm, foreign-issuer, sec-filing
Related Tickers: AZN
TL;DR
AZN filed a 6-K for AGM results, standard procedure.
AI Summary
AstraZeneca PLC filed a Form 6-K on April 11, 2025, reporting the results of its Annual General Meeting (AGM). The filing indicates that the company is a foreign issuer and provides its business and mailing address in Cambridge, UK.
Why It Matters
This filing provides shareholders and the market with official updates on the outcomes of AstraZeneca's Annual General Meeting, which can include voting on key corporate matters.
Risk Assessment
Risk Level: low — This is a routine filing reporting on the results of an Annual General Meeting, which is standard corporate practice.
Key Players & Entities
- AstraZeneca PLC (company) — Filer of the 6-K
- 001-11960 (company) — SEC File Number
- April 11, 2025 (date) — Filing date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign issuer required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
What specific event is reported in this 6-K filing?
This Form 6-K reports the results of AstraZeneca PLC's Annual General Meeting (AGM).
What is AstraZeneca PLC's SEC file number?
AstraZeneca PLC's SEC file number is 001-11960.
Where is AstraZeneca PLC's business address listed in the filing?
AstraZeneca PLC's business address is listed as 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.
Does AstraZeneca PLC file annual reports under Form 20-F or 40-F?
The filing indicates that AstraZeneca PLC files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 11, 2025 regarding ASTRAZENECA PLC (AZN).